MiniMed's IPO

Listed Mar 5, 2026 at $20 on Nasdaq as MMED.

Offer price
$20
Shares
28,000,000
Ticker
MMED

Today 9.2% below its $20 offer price; its first day closed -7.5%.

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

See MMED ranked, live

See it live, free until Saturday morning. No account. No card. Then keep going with a free account.

From its final prospectus (424B4) on SEC EDGAR, filed Mar 6, 2026.

What does MiniMed do?

“We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.”
From its final prospectus (424B4), filed Mar 6, 2026
MiniMed's facts, each with its source
FactMiniMed
Founded1983From its final prospectus (424B4) of Mar 6, 2026
IncorporatedDelaware, 2025From its final prospectus (424B4) of Mar 6, 2026
HeadquartersNorthridge, CaliforniaFrom its final prospectus (424B4) of Mar 6, 2026
Websiteminimed.comFrom its final prospectus (424B4) of Mar 6, 2026

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

MiniMed's facts, each with its source
FactMiniMed
Shares offered28,000,000From the final prospectus (424B4) filed Mar 6, 2026
Offer price$20 a shareFrom the final prospectus (424B4) filed Mar 6, 2026
Raised at that price$560 millionFrom the final prospectus (424B4) filed Mar 6, 2026
Underwriters' discount$22.4 millionFrom the final prospectus (424B4) filed Mar 6, 2026
Net proceeds the company expectsAbout $538 millionFrom the final prospectus (424B4) filed Mar 6, 2026
Underwriters' option4,200,000 more sharesFrom the final prospectus (424B4) filed Mar 6, 2026
UnderwritersGoldman Sachs, BofA Securities, Citigroup, Morgan Stanley, Barclays, and Deutsche Bank, and 6 moreFrom the final prospectus (424B4) filed Mar 6, 2026, as its cover names them
ExchangeNasdaq Global Select Market, as MMEDFrom the final prospectus (424B4) filed Mar 6, 2026

What risks does MiniMed name first?

  1. “We operate in a highly competitive industry and we may be unable to compete effectively.”
  2. “Competing products, therapeutic techniques, or other technological developments and breakthroughs for the monitoring, treatment, or prevention of diabetes may render our products obsolete or less desirable.”
  3. “We have experienced, and may continue to experience, pricing pressure for our products.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of MiniMed's IPO

MiniMed's IPO dates, each with its source
WhatDay
Registration filedForm S-1, SEC EDGARDec 19, 2025
Exchange registration filedexchange registration (Form 8-A), SEC EDGARMar 5, 2026
Pricedfinal prospectus (424B4), filed Mar 6, SEC EDGARMar 5, 2026
First tradeMassive's IPO calendarMar 5, 2026
Declared effective by the SECSEC notice of effectiveness, SEC EDGAROct 5, 2026
Lock-up endsfinal prospectus, SEC EDGAR: “180 days after the date of this prospectus”Sep 1, 2026

How did its first days trade?

From its daily bars, each close against its $20 offer price.

MiniMed's first sessions
DayOpenCloseFrom the
offer
Mar 6$19.05$18.49-7.6%
Mar 9$18.50$18-10.0%
Mar 10$18.03$18.33-8.4%
Mar 11$18.26$18.05-9.7%
Mar 12$18.35$16.53-17.3%

What is MiniMed's Quality Score?

0

Below Average

170 trading days so far; 1 of the 14 checks wait for more history.

MMED's page, with every reason behind its score

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

The other IPOs expected

The other IPOs expected or in registration
CompanyPrice

MiniMed IPO questions

When is MiniMed's IPO?

Listed Mar 5, 2026 at $20 on Nasdaq as MMED.

What is MiniMed's IPO price?

MiniMed's IPO priced at $20 a share, per its final prospectus of Mar 6, 2026.

How many shares is MiniMed selling?

28,000,000 shares, and the underwriters may buy 4,200,000 more, per its final prospectus (424B4).

Who are the underwriters?

Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley, Barclays, Deutsche Bank, Mizuho, Wells Fargo, Evercore ISI, Piper Sandler, BTIG, and William Blair, as the prospectus's cover names them.

When does the lock-up end?

MiniMed's IPO lock-⁠up ends Sep 1, 2026. Its final prospectus says: “180 days after the date of this prospectus.”

Does Breakaway rate MiniMed?

MiniMed has a Quality Score of 0 today. The score counts the 14 chart checks and the company's filings; a check that needs more history than a new stock has waits for it.

Can Breakaway say where MiniMed's price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

  • Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
  • The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
  • The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
  • The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
  • Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Every new listing, ranked live, free. No account.

See all 10 new listings ranked

See it live, free until Saturday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed, and March 2026's listings.

Sources: MiniMed Group, Inc.'s final prospectus (424B4) of Mar 6, 2026; the prices, the stock's daily bars, 15 minutes behind.

Not advice. Figures from each company's SEC filings, linked on each line. Breakaway is not an underwriter, broker, or adviser, and does not say where a price will go.

Scores as of 4:41 PM ET, 15 minutes behind.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.